Benzinga | May 5, 2021 04:39PM EDT

Global Blood Therapeutics Q1 EPS $(1.21) Misses $(1.01) Estimate, Sales $39.04M Miss $43.00M Estimate

Global Blood Therapeutics (NASDAQ:GBT) reported quarterly losses of $(1.21) per share which missed the analyst consensus estimate of $(1.01) by 19.8 percent. This is a 0.83 percent decrease over losses of $(1.20) per share from the same period last year. The company reported quarterly sales of $39.04 million which missed the analyst consensus estimate of $43.00 million by 9.20 percent. This is a 176.55 percent increase over sales of $14.12 million the same period last year.